Showing results (1481-1490 of 1,843) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Nonfederal average manufacturer price to estimate savings generated by minimum discounts under the Inflation Reduction ActInmaculada Hernandez, Nico Gabriel, Sean DicksonJournal of Managed Care & Specialty Pharmacy|October 27, 2023
Individual and social determinants of adherence to sodium-glucose cotransporter 2 inhibitor therapy: A trajectory analysisLanting Yang, Nico Gabriel, Jiang Bian, et al.Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Gene therapies for sickle cell disease: Effectiveness and valueDmitriy Nikitin, Francesca L Beaudoin, Praveen Thokala, et al.Journal of Managed Care & Specialty Pharmacy|September 30, 2023
Comparison of a second TNFi vs other biologic or targeted synthetic DMARD following an initial TNFiKori Asante, Patrick Racsa, Andrea Bloomfield, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defectsMatthew R Smith, Shahneen Sandhu, Daniel J George, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmaciesAutumn Zuckerman, Jared Crumb, Huda Marie Kandah, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancerHoward West, Xiaohan Hu, Su Zhang, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitisBinxin Cao, Susan L Hogan, Vimal K Derebail, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United StatesHye-Rim Kang, Pilar Hernandez-Con, Ji Haeng Heo, et al.Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United StatesAndrew P Brogan, Susan L Hogue, Renu M Vekaria, et al.Pageof 185